MJ

Mitesh Jayantilal Doshi

Active Director Designated Partner DIN 10012704
DIN 10012704 First appointment Jul 2022 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Mitesh Jayantilal Doshi

Data last updated:

Mitesh Jayantilal Doshi is a Designated Partner at Agilis Pharmaceuticals Llp (since 2022). The company operates in Paper.

DIN 10012704
Primary Designation Designated Partner
Industry Paper
First Appointment 25 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner25 Jul 20222022Under Process Of Striking Off

Board colleagues of Mitesh Jayantilal Doshi

NameDINCompanyDesignation
Ruchi Nimish Siria10012705Agilis Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Agilis Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Mitesh Jayantilal Doshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mitesh Jayantilal Doshi

Mitesh Jayantilal Doshi currently holds 1 directorship: Agilis Pharmaceuticals Llp (Designated Partner, since 25 Jul 2022).

Mitesh Jayantilal Doshi was first appointed on 25 Jul 2022 as Designated Partner at Agilis Pharmaceuticals Llp.

The current boards of Mitesh Jayantilal Doshi's companies include Ruchi Nimish Siria (Agilis Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available